Fellowship · Birmingham, AL
Sponsored by University of Alabama Hospital
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022 · 806 citations · Rita Basu
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
Journal of diabetes science and technology · 2023 · 237 citations · Ananda Basu
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.
The American journal of clinical nutrition · 2025 · 98 citations · Monica Agarwal
Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.
Obesity (Silver Spring, Md.) · 2025 · 86 citations · Monica Agarwal
American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease - 2025 Update.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025 · 83 citations ·
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · 153 citations · Basma Abdulhadi
Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity: A Randomized Clinical Trial.
JAMA internal medicine · 2022 · 231 citations · Amy Warriner
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD.
Journal of hepatology · 2025 · 65 citations · Fernando Bril